相关实验视频
Updated: May 5, 2026

11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
19.6K
在冠状动脉旁路移植 (pCAD-POAF) 后预防手术后心房动的部分心脏缩:随机对照试验研究协议
Ziang Yang1, Xieraili Tiemuerniyazi1, Shengkang Huang1
1Department of Cardiovascular Surgery, Fuwai Hospital; National Center for Cardiovascular Diseases; National Clinical Research Center for Cardiovascular Diseases; Chinese Academy of Medical Sciences; and Peking Union Medical College, Beijing, China.
The American journal of cardiology
|April 22, 2024
概括
在冠状动脉旁路移植 (CABG) 后,部分心脏脱皮可能会预防术后心房动 (POAF). 这项研究研究了这种新的手术方法在减少POAF发病率方面的疗效和安全性.
科学领域:
- 心血管外科心血管外科
- 心脏电生理学 心脏电生理学
- 手术创新 在外科创新.
背景情况:
- 手术后心房动 (POAF) 是冠状动脉旁路移植 (CABG) 后的一个常见并发症.
- POAF增加了患者的发病率,死亡率和医疗保健成本.
- 目前在CABG后预防POAF的策略有限.
研究的目的:
- 为了评估部分心脏消血在预防CABG后的POAF中的有效性.
- 评估部分心脏肌化的安全性和成本效益.
- 为了探索心脏缩对POAF的影响的解剖基础.
主要方法:
- 一项随机对照试验,涉及430名接受CABG的患者.
- 干预组接受了部分心脏缩 (马歇尔分裂带和沃特斯顿沟脂肪切除).
- 对POAF进行持续的术后监测,并进行30天的随访,包括心电图和心声回声.
主要成果:
- 该研究旨在确定主要终点:POAF的发病率.
- 二级终点包括成本效益和安全结果.
- 组织学分析和电刺激被用来确认自主性腺的存在.
结论:
- 这项试验将确定部分心脏脱皮是否可以降低CABG后的POAF发病率.
- 如果有效和安全,这种程序可以为POAF预防提供新的治疗选择.
- 这些发现可能会影响POAF风险的CABG患者的手术方案.
更多相关视频
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444

